Drugs giant Roche invests in Nvidia chips
Pharma giant Roche is adding a further 2,176 Nvidia GPUs to its internal “AI factory” which it says gives it the largest AI compute capacity of any pharmaceutical company.
The new infrastructure will be deployed across the US and Europe, supporting both Roche and its U.S. biotech subsidiary Genentech.
They plan to use the AI capacity across the entire drug lifecycle, from identifying biological targets and designing molecules to optimizing manufacturing and diagnostics.
They have already seen great results with
→ Designing an oncology molecule 25% faster using AI
→ Developing a therapy entering human trials by using AI to predict and reduce immune system reactions, increasing its chances of success.
Traditionally a new drug can take 10 years to develop and cost $1bn. By embedding AI holistically Roche hopes to "shorten timelines, tackle previously “undruggable” targets and improve productivity before patents expire."
SOURCE
